These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 30580964)

  • 1. p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.
    Moon SH; Huang CH; Houlihan SL; Regunath K; Freed-Pastor WA; Morris JP; Tschaharganeh DF; Kastenhuber ER; Barsotti AM; Culp-Hill R; Xue W; Ho YJ; Baslan T; Li X; Mayle A; de Stanchina E; Zender L; Tong DR; D'Alessandro A; Lowe SW; Prives C
    Cell; 2019 Jan; 176(3):564-580.e19. PubMed ID: 30580964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress.
    Kaymak I; Maier CR; Schmitz W; Campbell AD; Dankworth B; Ade CP; Walz S; Paauwe M; Kalogirou C; Marouf H; Rosenfeldt MT; Gay DM; McGregor GH; Sansom OJ; Schulze A
    Cancer Res; 2020 Jan; 80(2):189-203. PubMed ID: 31744820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR.
    Wong J; Quinn CM; Brown AJ
    Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 regulates the mevalonate pathway in human glioblastoma multiforme.
    Laezza C; D'Alessandro A; Di Croce L; Picardi P; Ciaglia E; Pisanti S; Malfitano AM; Comegna M; Faraonio R; Gazzerro P; Bifulco M
    Cell Death Dis; 2015 Oct; 6(10):e1909. PubMed ID: 26469958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOAT1 promotes mevalonate pathway dependency in pancreatic cancer.
    Oni TE; Biffi G; Baker LA; Hao Y; Tonelli C; Somerville TDD; Deschênes A; Belleau P; Hwang CI; Sánchez-Rivera FJ; Cox H; Brosnan E; Doshi A; Lumia RP; Khaledi K; Park Y; Trotman LC; Lowe SW; Krasnitz A; Vakoc CR; Tuveson DA
    J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32633781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.
    Freed-Pastor WA; Mizuno H; Zhao X; Langerød A; Moon SH; Rodriguez-Barrueco R; Barsotti A; Chicas A; Li W; Polotskaia A; Bissell MJ; Osborne TF; Tian B; Lowe SW; Silva JM; Børresen-Dale AL; Levine AJ; Bargonetti J; Prives C
    Cell; 2012 Jan; 148(1-2):244-58. PubMed ID: 22265415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-874 targets phosphomevalonate kinase and inhibits cancer cell growth via the mevalonate pathway.
    Aersilan A; Hashimoto N; Yamagata K; Yokoyama M; Nakayama A; Shi X; Nagano H; Sakuma I; Nohata N; Kinoshita T; Seki N; Rahmutulla B; Kaneda A; Zhahara SN; Gong Y; Nishimura M; Kawauchi S; Kawakami E; Tanaka T
    Sci Rep; 2022 Nov; 12(1):18443. PubMed ID: 36323841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle dependence on the mevalonate pathway: Role of cholesterol and non-sterol isoprenoids.
    Lasunción MA; Martínez-Botas J; Martín-Sánchez C; Busto R; Gómez-Coronado D
    Biochem Pharmacol; 2022 Feb; 196():114623. PubMed ID: 34052188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding the crosstalk between mevalonate metabolism and T cell function.
    Kennewick KT; Bensinger SJ
    Immunol Rev; 2023 Aug; 317(1):71-94. PubMed ID: 36999733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nuclear receptor FXR uncouples the actions of miR-33 from SREBP-2.
    Tarling EJ; Ahn H; de Aguiar Vallim TQ
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):787-95. PubMed ID: 25593129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
    Aylon Y; Gershoni A; Rotkopf R; Biton IE; Porat Z; Koh AP; Sun X; Lee Y; Fiel MI; Hoshida Y; Friedman SL; Johnson RL; Oren M
    Genes Dev; 2016 Apr; 30(7):786-97. PubMed ID: 27013235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferredoxin reductase and p53 are necessary for lipid homeostasis and tumor suppression through the ABCA1-SREBP pathway.
    Zhang Y; Mohibi S; Vasilatis DM; Chen M; Zhang J; Chen X
    Oncogene; 2022 Mar; 41(12):1718-1726. PubMed ID: 35121827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma.
    Liang B; Chen R; Song S; Wang H; Sun G; Yang H; Jing W; Zhou X; Fu Z; Huang G; Zhao J
    Cell Death Dis; 2019 Nov; 10(11):830. PubMed ID: 31685796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DHX33 mediates p53 to regulate mevalonate pathway gene transcription in human cancers.
    Nie G; Chen S; Song Q; Zou D; Li M; Tang X; Deng Y; Huang B; Yang M; Lv G; Zhang Y
    Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130547. PubMed ID: 38143011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms.
    Ahmadi Y; Ghorbanihaghjo A; Argani H
    Chem Biol Interact; 2017 Aug; 273():273-285. PubMed ID: 28668359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway.
    Pampalakis G; Obasuyi O; Papadodima O; Chatziioannou A; Zoumpourlis V; Sotiropoulou G
    Oncotarget; 2014 May; 5(9):2390-403. PubMed ID: 24158494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Liver Regeneration After Partial Hepatectomy in Sterol Regulatory Element-Binding Protein (SREBP)-1c-Null Mice is Associated with Increased Hepatocellular Cholesterol Availability.
    Peng J; Yu J; Xu H; Kang C; Shaul PW; Guan Y; Zhang X; Su W
    Cell Physiol Biochem; 2018; 47(2):784-799. PubMed ID: 29807364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mathematical model of the mevalonate cholesterol biosynthesis pathway.
    Pool F; Currie R; Sweby PK; Salazar JD; Tindall MJ
    J Theor Biol; 2018 Apr; 443():157-176. PubMed ID: 29355536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting mutant p53 through the mevalonate pathway.
    Freed-Pastor W; Prives C
    Nat Cell Biol; 2016 Oct; 18(11):1122-1124. PubMed ID: 27784901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.